{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:34:24Z","timestamp":1793662464528,"version":"4.5.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Department of Neurology, Mayo Clinic"},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA 497263"],"award-info":[{"award-number":["MDA 497263"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Symptomatic myopathy in sarcoidosis patients is not always due to sarcoid myopathy (ScM). We investigated the clinical and pathological spectrum including myxovirus resistance protein A (MxA) expression among sarcoidosis patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We reviewed the Mayo Clinic database (May 1980\u2013December 2020) to identify sarcoidosis patients with myopathic symptoms and pathological evidence of myopathy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 5885 sarcoidosis patients, 21 had symptomatic myopathy. Eight carried a diagnosis of sarcoidosis 5.5\u2009years (median) prior to myopathy onset. Eleven patients had ScM. The remaining had non-sarcoid myopathies (five IBM, one immune-mediated necrotizing myopathy, one non-specific myositis, two non-specific myopathy and one steroid myopathy). Estimated frequency of IBM is 85 per 100\u2009000 sarcoidosis patients. The following features were associated with non-sarcoid myopathies (P\u2009&amp;lt;\u20090.05): (i) predominant finger flexor and quadriceps weakness, (ii) modified Rankin scale (mRS) &amp;gt;2 at time of diagnosis, (iii) creatine kinase &amp;gt;500\u2009U\/l, and (iv) absence of intramuscular granulomas. Sarcoplasmic MxA expression was observed in scattered myofibres in three patients, two of whom were tested for DM-specific autoantibodies and were negative. Immunosuppressive therapy led to improvement in mRS \u22651 in 5\/10 ScM, none of the five IBM, and 3\/3 remaining patients with non-sarcoid myopathies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Symptomatic myopathy occurred in 0.36% of sarcoidosis. IBM was the second most common cause of myopathies after ScM. Frequency of IBM in sarcoidosis is higher than in the general population. Recognition of features suggestive of alternative aetiologies can guide proper treatment. Our findings of abnormal MxA expression warrant a larger study.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac668","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T13:30:19Z","timestamp":1669642219000},"page":"2556-2562","source":"Crossref","is-referenced-by-count":17,"title":["Symptomatic myopathies in sarcoidosis: disease spectrum and myxovirus resistance protein A expression"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9682-2372","authenticated-orcid":false,"given":"Pitcha","family":"Chompoopong","sequence":"first","affiliation":[{"name":"Division of Neuromuscular Medicine, Department of Neurology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Skolka","sequence":"additional","affiliation":[{"name":"Division of Neuromuscular Medicine, Department of Neurology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floranne C","family":"Ernste","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Milone","sequence":"additional","affiliation":[{"name":"Division of Neuromuscular Medicine, Department of Neurology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-5697","authenticated-orcid":false,"given":"Teerin","family":"Liewluck","sequence":"additional","affiliation":[{"name":"Division of Neuromuscular Medicine, Department of Neurology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"2023070511450731000_keac668-B1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(21)00311-8","article-title":"Misconceptions regarding symptoms of sarcoidosis","volume":"9","author":"Drent","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2023070511450731000_keac668-B2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"2023070511450731000_keac668-B3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2022.1570","article-title":"Diagnosis and treatment of pulmonary sarcoidosis: a review","volume":"327","author":"Belperio","year":"2022","journal-title":"JAMA"},{"key":"2023070511450731000_keac668-B4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rdc.2017.06.008","article-title":"Neurosarcoidosis","volume":"43","author":"Ungprasert","year":"2017","journal-title":"Rheum Dis Clin"},{"key":"2023070511450731000_keac668-B5","first-page":"280","article-title":"Muscle involvement in sarcoidosis","volume":"93","author":"Silverstein","year":"1968","journal-title":"Trans Am Neurol Assoc"},{"key":"2023070511450731000_keac668-B6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0049-0172(87)90008-4","article-title":"Myopathy in sarcoidosis: clinical and pathologic study of four cases and review of the literature","volume":"16","author":"Wolfe","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"2023070511450731000_keac668-B7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nmd.2018.10.007","article-title":"Myopathies featuring non-caseating granulomas: sarcoidosis, inclusion body myositis and an unfolding overlap","volume":"29","author":"Alhammad","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"2023070511450731000_keac668-B8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/S0317167100036684","article-title":"Inclusion body myositis associated with systemic sarcoidosis","volume":"13","author":"Danon","year":"1986","journal-title":"Can J Neurol Sci"},{"key":"2023070511450731000_keac668-B9","doi-asserted-by":"crossref","first-page":"e910","DOI":"10.1212\/WNL.0000000000008863","article-title":"Granulomatosis-associated myositis: high prevalence of sporadic inclusion body myositis","volume":"94","author":"Dieudonne","year":"2020","journal-title":"Neurology"},{"key":"2023070511450731000_keac668-B10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.nmd.2016.09.003","article-title":"Sporadic inclusion body myositis misdiagnosed as idiopathic granulomatous myositis","volume":"26","author":"Lavian","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"2023070511450731000_keac668-B11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nmd.2014.12.005","article-title":"Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseases","volume":"25","author":"Sanmaneechai","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"2023070511450731000_keac668-B12","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/rheumatology\/ken252","article-title":"Sarcoidosis and inclusion body myositis","volume":"47","author":"Vattemi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2023070511450731000_keac668-B13","first-page":"8469629","article-title":"Sarcoidosis: is it a possible trigger of inclusion body myositis?","volume":"2017","author":"Zakaria","year":"2017","journal-title":"Case Rep Rheumatol"},{"key":"2023070511450731000_keac668-B14","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1093\/rheumatology\/keaa530","article-title":"A unique case of co-existent sarcoidosis and immune-mediated necrotizing myopathy","volume":"60","author":"Koller-Smith","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023070511450731000_keac668-B15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/mus.27435","article-title":"Immune-mediated necrotizing myopathy: unusual presentations of a treatable disease","volume":"64","author":"Nicolau","year":"2021","journal-title":"Muscle Nerve"},{"key":"2023070511450731000_keac668-B16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/rheumatology\/keaa257","article-title":"Refining myositis associated with primary Sj\u00f6gren\u2019s syndrome: data from the prospective cohort ASSESS","volume":"60","author":"Felten","year":"2021","journal-title":"Rheumatology"},{"key":"2023070511450731000_keac668-B17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/rheumatology\/41.4.440","article-title":"Primary Sj\u00f6gren's syndrome associated with inclusion body myositis","volume":"41","author":"Kanellopoulos","year":"2002","journal-title":"Rheumatology"},{"key":"2023070511450731000_keac668-B18","article-title":"Granulomatous myopathy: sarcoidosis and beyond","author":"Chompoopong","year":"2022","journal-title":"Muscle Nerve"},{"key":"2023070511450731000_keac668-B19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression: a valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurology"},{"key":"2023070511450731000_keac668-B20","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2011.06.017","article-title":"Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway","volume":"66","author":"Judson","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2023070511450731000_keac668-B21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/jamaophthalmol.2015.0726","article-title":"Parallel gene expression changes in sarcoidosis involving the lacrimal gland, orbital tissue, or blood","volume":"133","author":"Rosenbaum","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"2023070511450731000_keac668-B22","first-page":"55","article-title":"Plasmacytoid dendritic cells in cutaneous sarcoidosis","volume":"35","author":"Halawi","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2023070511450731000_keac668-B23","first-page":"164","article-title":"The granulomatous inflammatory response. A review","volume":"84","author":"Adams","year":"1976","journal-title":"Am J Pathol"},{"key":"2023070511450731000_keac668-B24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/jcp.36.7.723","article-title":"Granulomatous inflammation\u2013a review","volume":"36","author":"Williams","year":"1983","journal-title":"J Clin Pathol"},{"key":"2023070511450731000_keac668-B25","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. an official american thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2023070511450731000_keac668-B26","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"188th ENMC International Workshop: inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"2023070511450731000_keac668-B27","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1212\/NXI.0000000000000452","article-title":"Symptomatic muscular sarcoidosis: lessons from a nationwide multicenter study","volume":"5","author":"Cohen Aubart","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2023070511450731000_keac668-B28","first-page":"98","article-title":"Muscle involvement in sarcoidosis: a retrospective and followup studies","volume":"33","author":"Fayad","year":"2006","journal-title":"J Rheumatol"},{"key":"2023070511450731000_keac668-B29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mus.20683","article-title":"Granulomatous myositis: a clinical study of thirteen cases","volume":"35","author":"Le Roux","year":"2007","journal-title":"Muscle Nerve"},{"key":"2023070511450731000_keac668-B30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-015-7680-0","article-title":"Clinicopathological features of sarcoidosis manifesting as generalized chronic myopathy","volume":"262","author":"Maeshima","year":"2015","journal-title":"J Neurol"},{"key":"2023070511450731000_keac668-B31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/rheumatology\/kex317","article-title":"A review of the musculoskeletal manifestations of sarcoidosis","volume":"57","author":"Bechman","year":"2018","journal-title":"Rheumatology"},{"key":"2023070511450731000_keac668-B32","doi-asserted-by":"crossref","first-page":"e2653","DOI":"10.1212\/WNL.0000000000012004","article-title":"Epidemiology and natural history of inclusion body myositis: a 40-year population-based study","volume":"96","author":"Shelly","year":"2021","journal-title":"Neurology"},{"key":"2023070511450731000_keac668-B33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2990.1997.tb01195.x","article-title":"Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes","volume":"23","author":"Authier","year":"1997","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2023070511450731000_keac668-B34","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1212\/WNL.0000000000013176","article-title":"Dermatomyositis: muscle pathology according to antibody subtypes","volume":"98","author":"Tanboon","year":"2022","journal-title":"Neurology"},{"key":"2023070511450731000_keac668-B35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/nan.12519","article-title":"Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis","volume":"45","author":"Uruha","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2023070511450731000_keac668-B36","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"New Engl J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac668\/47749655\/keac668.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/7\/2556\/50821737\/keac668.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/7\/2556\/50821737\/keac668.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T17:12:19Z","timestamp":1688577139000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/7\/2556\/6849509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,11,28]]},"published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac668","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2022,11,28]]}}}